Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01772030 · ClinicalTrials.gov registry record · NA
Atrial Fibrillation Recurrence After Cryoballoon Ablation
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT01772030 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 15 participants.
The verdict
NCT01772030, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the mechanisms of recurrent atrial fibrillation after cryoballoon ablation using the Arctic Front Ablation System. For those with pulmonary vein reconnection, specific sites of reconnection will be evaluated with left atrial intracardiac echo (ICE) guidance. The Achieve mapping catheter will be evaluated head-to-head with our current method of ICE-guided recordings from a conventional mapping catheter with high output pulmonary venous pacing.
Interventions
- OTHER Use of the Achieve catheter followed by ICE-guided mapping catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2013-01 |
| Est. Completion | 2019-08-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01772030
The ClinicalTrials.gov registry entry for NCT01772030 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Use of the Achieve catheter followed by ICE-guided mapping catheter is the first listed.
NCT01772030 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01772030 about?
NCT01772030 is a clinical study titled "Atrial Fibrillation Recurrence After Cryoballoon Ablation". The purpose of the study is to evaluate the mechanisms of recurrent atrial fibrillation after cryoballoon ablation using the Arctic Front Ablation System. For those with pulmonary vein reconnection, specific sites of reconnection will be evaluated with left atrial intracardiac echo (ICE) guidance. T...
What is the current status of trial NCT01772030?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2013-01. Estimated completion is 2019-08-07.
What interventions are being tested in trial NCT01772030?
The interventions under investigation include: Use of the Achieve catheter followed by ICE-guided mapping catheter (OTHER).
Who is sponsoring clinical trial NCT01772030?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.